| P50 | author | Hassan Fahmi | Q89553792 |
| P2093 | author name string | Qin Shi | |
| | Julio Fernandes | |
| | Mohamed Benderdour | |
| | Francis Vallières | |
| | Elsa-Patricia Rondon | |
| | Merve Kulbay | |
| | Houda Abir Benabdoun | |
| P2860 | cites work | EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update | Q26859134 |
| | Anti-inflammatory therapy in chronic disease: challenges and opportunities | Q26860162 |
| | Proresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis | Q27334082 |
| | The impact of four dynamic, goal-steered treatment strategies on the 5-year outcomes of rheumatoid arthritis patients in the BeSt study. | Q51160726 |
| | Lycium barbarum polysaccharide attenuates type II collagen-induced arthritis in mice. | Q53532309 |
| | Osteoarthritis cartilage histopathology: grading and staging. | Q53652403 |
| | A novel histone deacetylase 6-selective inhibitor suppresses synovial inflammation and joint destruction in a collagen antibody-induced arthritis mouse model. | Q53662447 |
| | The role of resolvin D1 in the regulation of inflammatory and catabolic mediators in osteoarthritis. | Q54201402 |
| | Immunopathogenesis of Rheumatoid Arthritis. | Q54430437 |
| | Elucidation of molecular mechanisms underlying the protective effects of thymoquinone against rheumatoid arthritis. | Q54647627 |
| | Rheumatoid arthritis | Q56656479 |
| | Resolvin D1 and Its Precursor Docosahexaenoic Acid Promote Resolution of Adipose Tissue Inflammation by Eliciting Macrophage Polarization toward an M2-Like Phenotype | Q61575249 |
| | Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor | Q73490934 |
| | Stimulation of 92-kd gelatinase (matrix metalloproteinase 9) production by interleukin-17 in human monocyte/macrophages: a possible role in rheumatoid arthritis | Q73806783 |
| | Spontaneous development of synovitis and cartilage degeneration in transgenic mice overexpressing cathepsin K | Q81576267 |
| | Perspectives From Masters in Rheumatology and Autoimmunity: Can We Get Closer to a Cure for Rheumatoid Arthritis? | Q85519450 |
| | FPR2/ALXR agonists and the resolution of inflammation | Q85900366 |
| | Resolvin D1 binds human phagocytes with evidence for proresolving receptors | Q28270638 |
| | Resolvin D1 Polarizes Primary Human Macrophages toward a Proresolution Phenotype through GPR32 | Q28274076 |
| | Resolvin D1, resolvin D2 and maresin 1 activate the GSK3β anti-inflammatory axis in TLR4-engaged human monocytes | Q29248096 |
| | Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not? | Q33683210 |
| | Effects of ω3- and ω6-polyunsaturated fatty acids on RANKL-induced osteoclast differentiation of RAW264.7 cells: a comparative in vitro study. | Q33963239 |
| | Proresolving lipid mediators and mechanisms in the resolution of acute inflammation | Q34411426 |
| | A novel anti-inflammatory and pro-resolving role for resolvin D1 in acute cigarette smoke-induced lung inflammation | Q34618718 |
| | Resolvins are potent analgesics for arthritic pain | Q35216459 |
| | Arachidonic acid and docosahexaenoic acid suppress osteoclast formation and activity in human CD14+ monocytes, in vitro | Q35388976 |
| | Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs | Q35951840 |
| | The X-Linked Inhibitor of Apoptosis Protein Inhibitor Embelin Suppresses Inflammation and Bone Erosion in Collagen Antibody Induced Arthritis Mice | Q35964123 |
| | Role of cathepsin K in normal joints and in the development of arthritis | Q36737790 |
| | Type II collagen autoimmunity in a mouse model of human rheumatoid arthritis | Q36984686 |
| | Expression of 5-lipoxygenase and 15-lipoxygenase in rheumatoid arthritis synovium and effects of intraarticular glucocorticoids | Q37270823 |
| | Resolvins and protectins: natural pharmacophores for resolution biology | Q37708842 |
| | The role of histone deacetylases in rheumatoid arthritis fibroblast-like synoviocytes | Q38108667 |
| | Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis | Q38176745 |
| | Treating to target in established rheumatoid arthritis: Challenges and opportunities in an era of novel targeted therapies and biosimilars. | Q38677219 |
| | Brief Report: Rheumatoid Arthritis as the Underlying Cause of Death in Thirty-One Countries, 1987-2011: Trend Analysis of World Health Organization Mortality Database | Q38829365 |
| | The cellular autophagy/apoptosis checkpoint during inflammation | Q39005984 |
| | Autoimmunity as a trigger for structural bone damage in rheumatoid arthritis | Q39067021 |
| | Immune resolution mechanisms in inflammatory arthritis | Q39067604 |
| | Resolvin D1 Programs Inflammation Resolution by Increasing TGF-β Expression Induced by Dying Cell Clearance in Experimental Autoimmune Neuritis. | Q39389096 |
| | Elucidating the Role of Protandim and 6-Gingerol in Protection Against Osteoarthritis | Q39555020 |
| | Resolvin D1 protects the liver from ischemia/reperfusion injury by enhancing M2 macrophage polarization and efferocytosis | Q39673867 |
| | Peripheral Interaction of Resolvin D1 and E1 with Opioid Receptor Antagonists for Antinociception in Inflammatory Pain in Rats | Q41222249 |
| | Prostaglandins and rheumatoid arthritis | Q41620695 |
| | Adenovirus-mediated delivery of Sema3A alleviates rheumatoid arthritis in a serum-transfer induced mouse model | Q42371628 |
| | Resolvin D1, an endogenous lipid mediator for inactivation of inflammation-related signaling pathways in microglial cells, prevents lipopolysaccharide-induced inflammatory responses. | Q42693504 |
| | The effects of polyunsaturated fatty acids and their metabolites on osteoclastogenesis in vitro | Q43098236 |
| | Antiinflammatory mediator lipoxin A4 and its receptor in synovitis of patients with rheumatoid arthritis | Q44391513 |
| | An inhibitor of cathepsin K, icariin suppresses cartilage and bone degradation in mice of collagen-induced arthritis. | Q46012525 |
| | In vivo therapeutic efficacy of TNFα silencing by folate-PEG-chitosan-DEAE/siRNA nanoparticles in arthritic mice | Q49387533 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 1 | |
| P577 | publication date | 2019-03-12 | |
| P1433 | published in | Arthritis Research and Therapy | Q15757229 |
| P1476 | title | In vitro and in vivo assessment of the proresolutive and antiresorptive actions of resolvin D1: relevance to arthritis | |
| P478 | volume | 21 | |